Skip to main content

Peer Review reports

From: Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours

Original Submission
12 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
3 Nov 2022 Reviewed Reviewer Report
15 Nov 2022 Reviewed Reviewer Report
2 Dec 2022 Author responded Author comments - Qin Yao
Resubmission - Version 3
2 Dec 2022 Submitted Manuscript version 3
4 Dec 2022 Author responded Author comments - Qin Yao
Resubmission - Version 4
4 Dec 2022 Submitted Manuscript version 4
6 Dec 2022 Author responded Author comments - Qin Yao
Resubmission - Version 5
6 Dec 2022 Submitted Manuscript version 5
14 Dec 2022 Reviewed Reviewer Report
3 Jan 2023 Author responded Author comments - Qin Yao
Resubmission - Version 6
3 Jan 2023 Submitted Manuscript version 6
Publishing
9 Jan 2023 Editorially accepted
13 Jan 2023 Article published 10.1186/s12885-023-10533-x

You can find further information about peer review here.

Back to article page